Akebia Therapeutics
AKBA
#6508
Rank
NZ$0.93 B
Marketcap
$3.57
Share price
3.38%
Change (1 day)
55.55%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$1.07

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.07. In 2022 the company made an earnings per share (EPS) of -$0.85 an increase over its 2021 EPS that were of -$2.84.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.0725.74%
2022-$0.85-70%
2021-$2.84-38.63%
2020-$4.6217.37%
2019-$3.942.79%
2018-$3.8331.2%
2017-$2.92-51.39%
2016-$6.0157.89%
2015-$3.81-94.83%
2014-$73.64589.75%
2013-$10.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$23.62-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.24-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$23.52-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.72 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA